# FDA Inspection 1151167 - Dayton Childrens Hospital - September 07, 2021

Source: https://www.keypedia.com/records/fda_inspections/dayton-childrens-hospital/929eb695-7560-4ba3-a4c4-731e445ecb93
Source feed: FDA_Inspections

> FDA Inspection 1151167 for Dayton Childrens Hospital on September 07, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1151167
- Company Name: Dayton Childrens Hospital
- Inspection Date: 2021-09-07
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1261998 - 2025-02-20](https://www.keypedia.com/records/fda_inspections/dayton-childrens-hospital/4e7b6d6d-1575-4fa0-ac2c-3b4e2566652e)
- [FDA Inspection 1261998 - 2025-02-20](https://www.keypedia.com/records/fda_inspections/dayton-childrens-hospital/9ff90c23-69bf-494e-a1af-2446f6efb333)
- [FDA Inspection 1151167 - 2021-09-07](https://www.keypedia.com/records/fda_inspections/dayton-childrens-hospital/57b51e5a-9d35-46b6-885d-2332a5ffb222)
- [FDA Inspection 1053801 - 2018-05-15](https://www.keypedia.com/records/fda_inspections/dayton-childrens-hospital/d2a6c763-0649-4b81-b2c0-0b22e5ad13ea)
- [FDA Inspection 959990 - 2016-02-29](https://www.keypedia.com/records/fda_inspections/dayton-childrens-hospital/b22f1445-cc91-4630-b6a0-4b503a08c07d)

Company: https://www.keypedia.com/companies/dayton-childrens-hospital/255d7064-3ee3-4494-9289-76cca7fddddd

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d